Yoshimitsu Kuwabara

No ORCID on file · 6 papers in corpus · active 2009-2023

Study types

  • article 6

Condition tags

  • adenomyosis 3
  • endometriosis 2
  • chronic_pelvic_pain 2
  • dysmenorrhea 1
article 2023
Carcinosarcoma of the uterus, derived from subserous cystic adenomyosis, presenting as an acute abdomen: A case report and review of the literature
Gynecologic oncology reports ·doi:10.1016/j.gore.2023.101139

When a woman presents with an acute abdomen with cystic lesions in the abdominal cavity, the differential diagnosis includes torsion or rupture of an ovarian tumor. We report our experience with a 54-year-old nulliparous woman who underwent…

article 2020
Distribution of dendritic cells in the septate uterus: An immunological perspective
·doi:10.1111/aji.13241

PROBLEM: Septate uterus is associated with spontaneous abortion. Surgical intervention of the uterine septa (US) is frequently performed following spontaneous abortion; however, immunological mechanisms for spontaneous abortion in patients …

article 2018
Efficacy of Dienogest in Thinning the Endometrium Before Hysteroscopic Metroplasty and Analysis of Postoperative Reproductive Outcomes
·doi:10.1089/gyn.2018.0015

Objective: This study was conducted to evaluate the efficacy of preoperative dienogest for thinning the endometrium in patients undergoing hysteroscopic metroplasty for septate uteri and to analyze postoperative reproductive outcomes. Mater…

article 2011
Proteomic Approach to Identify Specific Molecules Related to Ovarian Steroid Hormone-dependent Diseases
·doi:10.1272/jnms.78.57
article 2009
Efficacy of long-term, low-dose gonadotropin-releasing hormone agonist therapy (draw-back therapy) for adenomyosis.
Medical science monitor : international medical journal of experimental and clinical research

BACKGROUND: The usefulness of long-term, low-dose gonadotropin-releasing hormone agonist (GnRHa; buserelin acetate) therapy, so-called draw-back therapy, for the treatment of adenomyosis was investigated not. MATERIAL/METHODS: A retrospecti…

article 2009
Successful long-term management of adenomyosis associated with deep thrombosis by low-dose gonadotropin-releasing hormone agonist therapy.
Clinical and experimental obstetrics & gynecology

We report the case of a patient with adenomyosis complicated by deep vein thrombosis in whom low-dose gonadotropin-releasing hormone agonist (GnRHa) therapy was useful as a uterus-conserving therapeutic option. The patient was a 34-year-old…